Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    May 2017
  1. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


    April 2017
  2. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  3. BREAKWELL L, Anga J, Dadari I, Sadr-Azodi N, et al
    Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30473.
    PubMed     Text format     Abstract available


  4. JIANG HY, Wang SY, Deng M, Li YC, et al
    Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30432.
    PubMed     Text format     Abstract available


    March 2017
  5. LOBAINA Y, Michel ML
    Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30366.
    PubMed     Text format     Abstract available


  6. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  7. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


    February 2017
  8. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


    January 2017
  9. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  10. KARVONEN T, Auranen K, Kuusi M, Leino T, et al
    Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy.
    Vaccine. 2017;35:412-418.
    PubMed     Text format     Abstract available


  11. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available


    December 2016
  12. ZITT E, Hafner-Giessauf H, Wimmer B, Herr A, et al
    Response to active hepatitis B vaccination and mortality in incident dialysis patients.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31257.
    PubMed     Text format     Abstract available


  13. SAKAI A, Noguchi E, Fukushima T, Tagawa M, et al
    Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)30764.
    PubMed     Text format     Abstract available


  14. KANG W, Li Q, Shen L, Zhang L, et al
    Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31223.
    PubMed     Text format     Abstract available


    November 2016
  15. ALANKO BLOME M, Bjorkman P, Flamholc L, Jacobsson H, et al
    Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31102.
    PubMed     Text format     Abstract available


  16. LU Y, Liang XF, Wang FZ, Yan L, et al
    Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31123.
    PubMed     Text format     Abstract available


  17. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


  18. THOMPSON C, Dey A, Fearnley E, Polkinghorne B, et al
    Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31021.
    PubMed     Text format     Abstract available


  19. LIN X, Yang J, Lu H, Zhou Y, et al
    Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31069.
    PubMed     Text format     Abstract available


  20. YU HT, Wang JY, Tian D, Wang MX, et al
    Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
    Vaccine. 2016 Nov 11. pii: S0264-410X(16)30998.
    PubMed     Text format     Abstract available


    October 2016
  21. ZHANG X, Wei M, Sun G, Wang X, et al
    Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30980.
    PubMed     Text format     Abstract available


  22. XEUATVONGSA A, Datta SS, Moturi E, Wannemuehler K, et al
    Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30883.
    PubMed     Text format     Abstract available


    August 2016
  23. FAN W, Chen XF, Shen C, Guo ZR, et al
    Hepatitis B vaccine response in obesity: A meta-analysis.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30699.
    PubMed     Text format     Abstract available


    July 2016
  24. PATEL MK, Wannemuehler K, Tairi R, Tutai R, et al
    Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.
    Vaccine. 2016 Jul 8. pii: S0264-410X(16)30563.
    PubMed     Text format     Abstract available


    June 2016
  25. ZHANG L, Yan B, Xu A
    A hepatitis E outbreak by genotype 4 virus in Shandong province, China.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30409.
    PubMed     Text format     Abstract available


  26. HANKIN-WEI A, Rein DB, Hernandez-Romieu A, Kennedy MJ, et al
    Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30464.
    PubMed     Text format     Abstract available


  27. SONDLANE TH, Mawela L, Razwiedani LL, Selabe SG, et al
    High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30366.
    PubMed     Text format     Abstract available


    May 2016
  28. DINDA AK, Bhat M, Srivastava S, Kottarath SK, et al
    Novel nanocarrier for oral Hepatitis B vaccine.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30258.
    PubMed     Text format     Abstract available


    April 2016
  29. ZHU FC, Sun KX, Pan HX, Yang ZH, et al
    The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10mug recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30196.
    PubMed     Text format     Abstract available


  30. LEVANDER S, Sallberg M, Ahlen G, Frelin L, et al
    A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30171.
    PubMed     Text format     Abstract available


  31. SADOH AE, Nwaneri DU, Ogboghodo BC, Sadoh WE, et al
    Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30164.
    PubMed     Text format     Abstract available


  32. BERAN J, Van Der Meeren O, Leyssen M, D'silva P, et al
    Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30174.
    PubMed     Text format     Abstract available


  33. VAN DER MEEREN O, Behre U, Crasta P
    Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.
    Vaccine. 2016 Apr 16. pii: S0264-410X(16)30142.
    PubMed     Text format     Abstract available


  34. ROH EY, Yoon JH, In JW, Lee N, et al
    Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30087.
    PubMed     Text format     Abstract available


  35. ALLISON RD, Teleb N, Al Awaidy S, Ashmony H, et al
    Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization.
    Vaccine. 2016 Apr 2. pii: S0264-410X(16)30059.
    PubMed     Text format     Abstract available


    March 2016
  36. KOLWAITE AR, Xeuatvongsa A, Ramirez-Gonzalez A, Wannemuehle K, et al
    Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30077.
    PubMed     Text format     Abstract available


  37. WIESEN E, Diorditsa S, Li X
    Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30056.
    PubMed     Text format     Abstract available


  38. DULAL P, Wright D, Ashfield R, Hill AV, et al
    Potency of a thermostabilised chimpanzee adenovirus Rift Valley fever vaccine in cattle.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30057.
    PubMed     Text format     Abstract available


  39. FEIRING B, Laake I, Molden T, Haberg SE, et al
    Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00255.
    PubMed     Text format     Abstract available


  40. FUSTER F, Vargas JI, Jensen D, Sarmiento V, et al
    CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00236.
    PubMed     Text format     Abstract available


    February 2016
  41. SALAMA II, Sami SM, Salama SI, Rabah TM, et al
    Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00231.
    PubMed     Text format     Abstract available


  42. KUMAR M, Upadhyay A, Singh J, Chhabra M, et al
    Effect of change in sequence of administration of DTwP and Hepatitis B vaccines on perception of pain in infants: A randomized control trial.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00173.
    PubMed     Text format     Abstract available


    January 2016
  43. WANG ZZ, Li MQ, Wang P, Yang ZX, et al
    Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
    Vaccine. 2016 Jan 19. pii: S0264-410X(16)00044.
    PubMed     Text format     Abstract available


  44. XIA M, Wei C, Wang L, Cao D, et al
    A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Vaccine. 2016 Jan 9. pii: S0264-410X(16)00017.
    PubMed     Text format     Abstract available


  45. BACKES S, Jager C, Dembek CJ, Kosinska AD, et al
    Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01871.
    PubMed     Text format     Abstract available


    December 2015
  46. DOEDEE AM, Kannegieter N, Ozturk K, van Loveren H, et al
    Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01799.
    PubMed     Text format     Abstract available


  47. HUMMEL IB, Zitzmann A, Erl M, Wenzel JJ, et al
    Characteristics of immune memory 10-15 years after primary hepatitis B vaccination.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01824.
    PubMed     Text format     Abstract available


  48. PITTMAN PR, McClain D, Quinn X, Coonan KM, et al
    Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01821.
    PubMed     Text format     Abstract available


  49. PITTMAN PR, Norris SL, Brown ES, Ranadive MV, et al
    Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01775.
    PubMed     Text format     Abstract available


  50. KUMAR A, Das S, Mullick R, Lahiri P, et al
    Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01727.
    PubMed     Text format     Abstract available


  51. JING M, Wang J, Zhu S, Ao F, et al
    Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01750.
    PubMed     Text format     Abstract available


  52. CHONWATTANA W, Raengsakulrach B, Holtz TH, Wasinrapee P, et al
    Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01765.
    PubMed     Text format     Abstract available


  53. VAN EFFELTERRE T, Marano C, Jacobsen KH
    Modeling the hepatitis A epidemiological transition in Thailand.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01702.
    PubMed     Text format     Abstract available


    November 2015
  54. WIESEN E, Lagani W, Sui G, Arava J, et al
    Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01686.
    PubMed     Text format     Abstract available


  55. SU FH, Huang YL, Sung FC, Su CT, et al
    Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: A population-based analysis.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01585.
    PubMed     Text format     Abstract available


    August 2015
  56. MANSFIELD KL, Banyard AC, McElhinney L, Johnson N, et al
    Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Vaccine. 2015 Aug 18. pii: S0264-410X(15)01134.
    PubMed     Text format     Abstract available


    June 2015
  57. HAYDEN CA, Fischer ME, Andrews BL, Chilton HC, et al
    Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Vaccine. 2015;33:2881-6.
    PubMed     Text format     Abstract available


    May 2015
  58. AVDICOVA M, Crasta PD, Hardt K, Kovac M, et al
    Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Vaccine. 2015;33:2727-33.
    PubMed     Text format     Abstract available


    February 2015
  59. KAWANO Y, Suzuki M, Kawada JI, Kimura H, et al
    Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00132.
    PubMed     Text format     Abstract available


  60. WICHGERS SCHREUR PJ, Kant J, van Keulen L, Moormann RJ, et al
    Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00134.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: